Skip to main content
. Author manuscript; available in PMC: 2024 Jun 26.
Published in final edited form as: J Neurosurg. 2023 Jan 13;139(2):402–413. doi: 10.3171/2022.12.JNS221490

FIG. 3.

FIG. 3.

Graphs showing the impact of LMD on survival and the impact of treatment on LMD outcomes. A: Patients who developed LMD in the postoperative setting had shorter survival from the date of first surgery (median 16.1 vs 36.7 months, p < 0.0001). B: LMD subtype was also associated with survival duration (cLMD vs nLMD vs no LMD: median 16.1 vs 15.4 vs 36.7 months, p < 0.0001). C: Treatment (Tx) after LMD diagnosis resulted in improved survival time (treatment vs none: median 6.5 vs 1.1 months, p = 0.0007).